Alveolar macrophages drive lung fibroblast function in cocultures of IPF and normal patient samples.
fibroblasts
fibrosis
lung
monocyte/macrophage
Journal
American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229
Informations de publication
Date de publication:
01 04 2023
01 04 2023
Historique:
pmc-release:
01
04
2024
medline:
29
3
2023
pubmed:
16
2
2023
entrez:
15
2
2023
Statut:
ppublish
Résumé
Idiopathic pulmonary fibrosis (IPF) is characterized by increased collagen accumulation that is progressive and nonresolving. Although fibrosis progression may be regulated by fibroblasts and alveolar macrophage (AM) interactions, this cellular interplay has not been fully elucidated. To study AM-fibroblast interactions, cells were isolated from IPF and normal human lung tissue and cultured independently or together in direct 2-D coculture, direct 3-D coculture, indirect transwell, and in 3-D hydrogels. AM influence on fibroblast function was assessed by gene expression, cytokine/chemokine secretion, and hydrogel contractility. Normal AMs cultured in direct contact with fibroblasts downregulated extracellular matrix (ECM) gene expression whereas IPF AMs had little to no effect. Fibroblast contractility was assessed by encapsulating cocultures in 3-D collagen hydrogels and monitoring gel diameter over time. Both normal and IPF AMs reduced baseline contractility of normal fibroblasts but had little to no effect on IPF fibroblasts. When stimulated with Toll-like receptor (TLR) agonists, IPF AMs increased production of pro-inflammatory cytokines TNFα and IL-1β, compared with normal AMs. TLR ligand stimulation did not alter fibroblast contraction, but stimulation with exogenous TNFα and TGFβ did alter contraction. To determine if the observed changes required cell-to-cell contact, AM-conditioned media and transwell systems were utilized. Transwell culture showed decreased ECM gene expression changes compared with direct coculture and conditioned media from AMs did not alter fibroblast contraction regardless of disease state. Taken together, these data indicate that normal fibroblasts are more responsive to AM crosstalk, and that AM influence on fibroblast behavior depends on cell proximity.
Identifiants
pubmed: 36791050
doi: 10.1152/ajplung.00263.2022
pmc: PMC10259863
doi:
Substances chimiques
Tumor Necrosis Factor-alpha
0
Culture Media, Conditioned
0
Cytokines
0
Collagen
9007-34-5
Banques de données
figshare
['10.6084/m9.figshare.20503482']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
L507-L520Subventions
Organisme : NHLBI NIH HHS
ID : F32 HL164020
Pays : United States
Références
Respir Med. 2012 Dec;106(12):1800-3
pubmed: 22999220
Am J Respir Cell Mol Biol. 2003 Dec;29(6):669-76
pubmed: 12816730
Int J Biochem Cell Biol. 2008;40(10):2174-82
pubmed: 18395486
Nat Commun. 2019 Apr 23;10(1):1850
pubmed: 31015429
J Clin Med. 2016 Sep 02;5(9):
pubmed: 27598213
Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
pubmed: 16415274
Front Immunol. 2018 Jun 01;9:1216
pubmed: 29910813
Clin Epidemiol. 2013 Nov 25;5:483-92
pubmed: 24348069
Cells. 2020 Feb 18;9(2):
pubmed: 32085494
Plast Reconstr Surg. 2021 Feb 1;147(2):231e-239e
pubmed: 33235042
Toxicol Appl Pharmacol. 2019 Mar 1;366:10-16
pubmed: 30653976
Annu Rev Physiol. 2017 Feb 10;79:567-592
pubmed: 27959619
J Cell Mol Med. 2020 Jan;24(1):13-24
pubmed: 31642585
BMC Pulm Med. 2014 Aug 16;14:139
pubmed: 25127540
Exp Lung Res. 2019 Nov - Dec;45(9-10):288-296
pubmed: 31762326
Ann Am Thorac Soc. 2016 Dec;13 Suppl 5:S417-S421
pubmed: 28005427
Sci Rep. 2021 Jan 14;11(1):1474
pubmed: 33446687
Am J Respir Cell Mol Biol. 2014 Apr;50(4):825-37
pubmed: 24325577
Lab Invest. 2022 Apr;102(4):432-439
pubmed: 34775492
J Exp Med. 2017 Aug 7;214(8):2387-2404
pubmed: 28694385
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Am J Physiol Lung Cell Mol Physiol. 2021 Sep 1;321(3):L518-L532
pubmed: 34231378
Int Immunopharmacol. 2014 May;20(1):66-73
pubmed: 24583146
Am J Respir Cell Mol Biol. 2016 Jan;54(1):13-24
pubmed: 26267148
Cell Immunol. 2000 Aug 25;204(1):19-28
pubmed: 11006014
Int Immunopharmacol. 2019 Jul;72:385-394
pubmed: 31030094
Respir Res. 2019 Nov 27;20(1):264
pubmed: 31775876
J Pathol. 2008 Jan;214(2):149-60
pubmed: 18161752
Immunobiology. 2008;213(7):533-44
pubmed: 18656701
Adv Biosyst. 2020 Jan;4(1):e1900220
pubmed: 32293120
Curr Opin Pulm Med. 2015 Sep;21(5):454-62
pubmed: 26176965
Adv Healthc Mater. 2019 Feb;8(4):e1801451
pubmed: 30658015
J Biol Chem. 1988 Apr 25;263(12):5841-5
pubmed: 3258601
Am J Respir Cell Mol Biol. 2016 Jan;54(1):147-9
pubmed: 26274047
J Leukoc Biol. 1998 Nov;64(5):636-41
pubmed: 9823769
J Histochem Cytochem. 2016 Aug;64(8):470-82
pubmed: 27370795
Cell Mol Life Sci. 2020 Aug;77(16):3161-3176
pubmed: 32100084
Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L510-8
pubmed: 21743030
J Inflamm Res. 2013;6:25-33
pubmed: 23576875
Cytokine. 2018 Oct;110:63-69
pubmed: 29704820
Toxicol Appl Pharmacol. 2019 Oct 1;380:114698
pubmed: 31394157
Nat Rev Cancer. 2009 May;9(5):361-71
pubmed: 19343034
Am J Respir Crit Care Med. 2008 Nov 1;178(9):948-55
pubmed: 18669816